Seventh Sense Biosystems Inc. Receives Notices Of Allowance For Three U.S. Patents For TAP Blood Collection System

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seventh Sense Biosystems, Inc., (7SBio), a leading developer of blood collection and diagnostic platforms, announced today the receipt of notices of allowance from the United States Patent and Trademark Office for three patent applications (U.S. Patent Applications 13/680,351, 13/456,570, and 13/292,254).

The allowed claims cover blood collection devices including TAP devices for the collection of any volume of blood and the use of microneedles, microfluidics and a vacuum to cause blood flow. These patent allowances are paramount to protecting and building out 7SBio’s proprietary Touch Activated Phlebotomy (TAP) technology platform and the core design of the TAP devices.

Help employers find you! Check out all the jobs and post your resume.

Back to news